These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 8971064)

  • 1. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
    Clark LC; Combs GF; Turnbull BW; Slate EH; Chalker DK; Chow J; Davis LS; Glover RA; Graham GF; Gross EG; Krongrad A; Lesher JL; Park HK; Sanders BB; Smith CL; Taylor JR
    JAMA; 1996 Dec; 276(24):1957-63. PubMed ID: 8971064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.
    Clark LC; Dalkin B; Krongrad A; Combs GF; Turnbull BW; Slate EH; Witherington R; Herlong JH; Janosko E; Carpenter D; Borosso C; Falk S; Rounder J
    Br J Urol; 1998 May; 81(5):730-4. PubMed ID: 9634050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.
    Duffield-Lillico AJ; Slate EH; Reid ME; Turnbull BW; Wilkins PA; Combs GF; Park HK; Gross EG; Graham GF; Stratton MS; Marshall JR; Clark LC;
    J Natl Cancer Inst; 2003 Oct; 95(19):1477-81. PubMed ID: 14519754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
    Moon TE; Levine N; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):949-56. PubMed ID: 9367069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of cancer risk with an oral supplement of selenium.
    Combs GF; Clark LC; Turnbull BW
    Biomed Environ Sci; 1997 Sep; 10(2-3):227-34. PubMed ID: 9315315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.
    Duffield-Lillico AJ; Reid ME; Turnbull BW; Combs GF; Slate EH; Fischbach LA; Marshall JR; Clark LC
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):630-9. PubMed ID: 12101110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial.
    Green A; Williams G; Neale R; Hart V; Leslie D; Parsons P; Marks GC; Gaffney P; Battistutta D; Frost C; Lang C; Russell A
    Lancet; 1999 Aug; 354(9180):723-9. PubMed ID: 10475183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of cancer mortality and incidence by selenium supplementation.
    Combs GF; Clark LC; Turnbull BW
    Med Klin (Munich); 1997 Sep; 92 Suppl 3():42-5. PubMed ID: 9342915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
    Levine N; Moon TE; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):957-61. PubMed ID: 9367070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
    Weinstock MA; Thwin SS; Siegel JA; Marcolivio K; Means AD; Leader NF; Shaw FM; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin GP; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri JE; Robinson-Bostom L; Ringer RJ; Lew RA; Ferguson R; DiGiovanna JJ; Huang GD;
    JAMA Dermatol; 2018 Feb; 154(2):167-174. PubMed ID: 29299592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
    Elmets CA; Viner JL; Pentland AP; Cantrell W; Lin HY; Bailey H; Kang S; Linden KG; Heffernan M; Duvic M; Richmond E; Elewski BE; Umar A; Bell W; Gordon GB
    J Natl Cancer Inst; 2010 Dec; 102(24):1835-44. PubMed ID: 21115882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial.
    Reid ME; Duffield-Lillico AJ; Garland L; Turnbull BW; Clark LC; Marshall JR
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1285-91. PubMed ID: 12433704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.
    Lee IM; Cook NR; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
    JAMA; 2005 Jul; 294(1):56-65. PubMed ID: 15998891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
    Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL
    N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.
    Frieling UM; Schaumberg DA; Kupper TS; Muntwyler J; Hennekens CH
    Arch Dermatol; 2000 Feb; 136(2):179-84. PubMed ID: 10677093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nutritional prevention of cancer: 400 mcg per day selenium treatment.
    Reid ME; Duffield-Lillico AJ; Slate E; Natarajan N; Turnbull B; Jacobs E; Combs GF; Alberts DS; Clark LC; Marshall JR
    Nutr Cancer; 2008; 60(2):155-63. PubMed ID: 18444146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of selenium intake on the prevention of cutaneous epithelial lesions in organ transplant recipients.
    Dréno B; Euvrard S; Frances C; Moyse D; Nandeuil A
    Eur J Dermatol; 2007; 17(2):140-5. PubMed ID: 17337398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.
    Mayne ST; Cartmel B; Baum M; Shor-Posner G; Fallon BG; Briskin K; Bean J; Zheng T; Cooper D; Friedman C; Goodwin WJ
    Cancer Res; 2001 Feb; 61(4):1457-63. PubMed ID: 11245451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study.
    Bavinck JN; Tieben LM; Van der Woude FJ; Tegzess AM; Hermans J; ter Schegget J; Vermeer BJ
    J Clin Oncol; 1995 Aug; 13(8):1933-8. PubMed ID: 7636533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.